T s zmluvne zaviazan zabezpei dvernos vaich dajov prostrednctvom dohody o spracvan dajov
Johnson B, Haymaker CL, Parra ER, Soto LMS, Wang X, Thomas JV, Dasari A, Morris VK, Raghav K, Vilar E, Kee BK, Eng C, Parseghian CM, Wolff RA, Lee Y, Lorenzini D, Laberiano-Fernandez C, Verma A, Lang W, Wistuba II, Futreal A, Kopetz S , Overman MJ
Diversify your diet as much as possible to cover all micronutrient bases
reported that humans who were administered GLP-1RA (liraglutide) lost weight and experienced a modest shift toward fat oxidation and decreased energy expenditure, indicating that human weight loss is primarily a result of a reduction in food intake caused by GLP-1R agonism [23]
Research has shown that individuals who go off of a GLP-1 drug tend to regain much of the weight lost